Comparator sourcing: Leveraging the Bolar exemption to accelerate market access for generic and biosimilar products
Comparator sourcing: Leveraging the Bolar exemption to accelerate market access for generic and biosimilar products
Thermo Fisher의 대조약 팀은 볼라 조항을 활용하는 데 필요한 전문성을 갖추고 있으며 고객의 제네릭/바이오시밀러 약물을 가속화할 수 있도록 지원합니다.

Added Date:

2022-12-27

Filters:

Filter Category Filter Values
Specialty
  • Comparator
  • sourcing and optimization
  • Clinical supply demand planning, sourcing and optimization
Capability
  • Clinical trial solutions
  • Clinical supply solutions
Year
  • 2022
Language
  • Korean
Asset Type
  • Whitepaper
Region
  • Asia Pacific (APAC)
Country
  • Korea
Market Category
  • Clinical trial services

Country Availability:


()

Gated Form:

None Set